BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

240 related articles for article (PubMed ID: 33982796)

  • 1. Implementation of oral anticoagulation treatment guidelines in patients with newly diagnosed atrial fibrillation.
    Arbel A; Abu-Ful Z; Preis M; Cohen S; Saliba W
    Br J Clin Pharmacol; 2021 Dec; 87(12):4747-4755. PubMed ID: 33982796
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Use of oral anticoagulation therapy in the first 3 months after the diagnosis of atrial fibrillation in Israel: A population-based study.
    Kezerle L; Tsadok MA; Berliner Senderey A; Hoshen M; Leventer-Roberts M; Reges O; Leibowitz M; Haim M
    J Cardiovasc Electrophysiol; 2020 Jun; 31(6):1356-1363. PubMed ID: 32212197
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Factors associated with oral anticoagulant prescription status among patients with a new diagnosis of atrial fibrillation.
    Manning E; Burns K; Laurie M; Patten L; Ho M; Sandhu A
    Clin Cardiol; 2023 Aug; 46(8):937-941. PubMed ID: 37401357
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Stroke-prevention strategies in North American patients with atrial fibrillation: The GLORIA-AF registry program.
    McIntyre WF; Conen D; Olshansky B; Halperin JL; Hayek E; Huisman MV; Lip GYH; Lu S; Healey JS
    Clin Cardiol; 2018 Jun; 41(6):744-751. PubMed ID: 29546729
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Influence of Direct Oral Anticoagulants on Rates of Oral Anticoagulation for Atrial Fibrillation.
    Marzec LN; Wang J; Shah ND; Chan PS; Ting HH; Gosch KL; Hsu JC; Maddox TM
    J Am Coll Cardiol; 2017 May; 69(20):2475-2484. PubMed ID: 28521884
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Do CHA2 DS2 VASc and HAS-BLED scores influence 'real-world' anticoagulation management in atrial fibrillation? 1556 patient registry from the reference cardiology centre.
    Lopatowska P; Tomaszuk-Kazberuk A; Mlodawska E; Bachorzewska-Gajewska H; Malyszko J; Dobrzycki S; Musial WJ
    Pharmacoepidemiol Drug Saf; 2015 Dec; 24(12):1297-303. PubMed ID: 26419506
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Global Oral Anticoagulation Use Varies by Region in Patients With Recent Diagnosis of Atrial Fibrillation: The GLORIA-AF Phase III Registry.
    Bayer V; Kotalczyk A; Kea B; Teutsch C; Larsen P; Button D; Huisman MV; Lip GYH; Olshansky B
    J Am Heart Assoc; 2022 Mar; 11(6):e023907. PubMed ID: 35243870
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Prescription Patterns and Outcomes of Patients With Atrial Fibrillation Treated With Direct Oral Anticoagulants and Warfarin: A Real-World Analysis.
    Kattoor AJ; Pothineni NV; Goel A; Syed M; Syed S; Paydak H; Mehta JL
    J Cardiovasc Pharmacol Ther; 2019 Sep; 24(5):428-434. PubMed ID: 31035795
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The Tasmanian atrial fibrillation study: Transition to direct oral anticoagulants 2011-2015.
    Alamneh EA; Chalmers L; Bereznicki LR
    Cardiovasc Ther; 2017 Jun; 35(3):. PubMed ID: 28177198
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Underuse of oral anticoagulants in privately insured patients with atrial fibrillation: A population being targeted by the IMplementation of a randomized controlled trial to imProve treatment with oral AntiCoagulanTs in patients with Atrial Fibrillation (IMPACT-AFib).
    Al-Khatib SM; Pokorney SD; Al-Khalidi HR; Haynes K; Garcia C; Martin D; Goldsack JC; Harkins T; Cocoros NM; Lin ND; Lipowicz H; McCall D; Nair V; Parlett L; McMahill-Walraven CN; Platt R; Granger CB
    Am Heart J; 2020 Nov; 229():110-117. PubMed ID: 32949986
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Prescription of oral anticoagulants and antiplatelets for stroke prophylaxis in atrial fibrillation: nationwide time series ecological analysis.
    Wu J; Alsaeed ES; Barrett J; Hall M; Cowan C; Gale CP
    Europace; 2020 Sep; 22(9):1311-1319. PubMed ID: 32778878
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The association between increasing oral anticoagulant prescribing and atrial fibrillation related stroke in Ireland.
    Kennedy C; Gabr A; McCormack J; Collins R; Barry M; Harbison J
    Br J Clin Pharmacol; 2022 Jan; 88(1):178-186. PubMed ID: 34131941
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Oral Anticoagulant Prescription Trends, Profile Use, and Determinants of Adherence in Patients with Atrial Fibrillation.
    Perreault S; de Denus S; White-Guay B; Côté R; Schnitzer ME; Dubé MP; Dorais M; Tardif JC
    Pharmacotherapy; 2020 Jan; 40(1):40-54. PubMed ID: 31758592
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Oral anticoagulation after catheter ablation of atrial fibrillation and the associated risk of thromboembolic events and intracranial hemorrhage: A systematic review and meta-analysis.
    Romero J; Cerrud-Rodriguez RC; Diaz JC; Rodriguez D; Arshad S; Alviz I; Cerna L; Rios S; Monhanty S; Natale A; Garcia MJ; Di Biase L
    J Cardiovasc Electrophysiol; 2019 Aug; 30(8):1250-1257. PubMed ID: 31257677
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Real-World Clinical Characteristics and Treatment Patterns of Individuals Aged 80 and Older with Nonvalvular Atrial Fibrillation: Results from the ReAl-life Multicenter Survey Evaluating Stroke Study.
    Biteker M; Başaran Ö; Doğan V; Altun İ; Özpamuk Karadeniz F; Tekkesin Aİ; Çakıllı Y; Türkkan C; Hamidi M; Demir V; Gürsoy MO; Tek Öztürk M; Aksan G; Seyis S; Ballı M; Alıcı MH; Bozyel S
    J Am Geriatr Soc; 2017 Aug; 65(8):1684-1690. PubMed ID: 28394435
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Incidence of nonvalvular atrial fibrillation and oral anticoagulant prescribing in England, 2009 to 2019: A cohort study.
    Ajabnoor AM; Zghebi SS; Parisi R; Ashcroft DM; Rutter MK; Doran T; Carr MJ; Mamas MA; Kontopantelis E
    PLoS Med; 2022 Jun; 19(6):e1004003. PubMed ID: 35671329
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Use of Oral Anticoagulant Therapy in Older Adults with Atrial Fibrillation After Acute Ischemic Stroke.
    McGrath ER; Go AS; Chang Y; Borowsky LH; Fang MC; Reynolds K; Singer DE
    J Am Geriatr Soc; 2017 Feb; 65(2):241-248. PubMed ID: 28039855
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effectiveness and Safety of Direct Oral Anticoagulants in an Asian Population with Atrial Fibrillation Undergoing Dialysis: A Population-Based Cohort Study and Meta-Analysis.
    See LC; Lee HF; Chao TF; Li PR; Liu JR; Wu LS; Chang SH; Yeh YH; Kuo CT; Chan YH; Lip GYH
    Cardiovasc Drugs Ther; 2021 Oct; 35(5):975-986. PubMed ID: 33211254
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Country and health expenditure are major predictors of withholding anticoagulation in atrial fibrillation patients at high risk of stroke.
    Siegal DM; Verbrugge FH; Martin AC; Virdone S; Camm J; Pieper K; Gersh BJ; Goto S; Turpie AGG; Angchaisuksiri P; Fox KAA
    Open Heart; 2023 Dec; 10(2):. PubMed ID: 38097360
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Increased use of oral anticoagulants in patients with atrial fibrillation: temporal trends from 2005 to 2015 in Denmark.
    Gadsbøll K; Staerk L; Fosbøl EL; Sindet-Pedersen C; Gundlund A; Lip GYH; Gislason GH; Olesen JB
    Eur Heart J; 2017 Mar; 38(12):899-906. PubMed ID: 28110293
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.